Form 4: Tenaya Therapeutics Executive Sells Shares

Sentiment:

Insider Transaction (Form 4)


Whittemore Tingley, Chief Medical Officer of Tenaya Therapeutics, Inc., sold 7,424 shares of common stock on August 17, 2026 for $0.71 per share.

Summary

  • Open-market sale: disposed of 1,637 Common Stock at $0.71 ($1,162) on August 17, 2026; holds 219,860 after (Direct).
  • Open-market sale: disposed of 1,637 Common Stock at $0.71 ($1,162) on August 17, 2026; holds 218,223 after (Direct).
  • Open-market sale: disposed of 1,871 Common Stock at $0.71 ($1,328) on August 17, 2026; holds 216,352 after (Direct).
  • Open-market sale: disposed of 2,279 Common Stock at $0.71 ($1,618) on August 17, 2026; holds 214,073 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $5,270 of stock on the open market.

Insider Transactions

Whittemore Tingley — Officer (Chief Medical Officer)

DateTransactionSecuritySharesPriceValueHeld After
2026-08-17Open-market saleCommon Stock1,637$1$1.2K219,860
2026-08-17Open-market saleCommon Stock1,637$1$1.2K218,223
2026-08-17Open-market saleCommon Stock1,871$1$1.3K216,352
2026-08-17Open-market saleCommon Stock2,279$1$1.6K214,073

Key Dates

DateDescription
2026-08-17Open-market sale (1,637 shares)
2026-08-17Open-market sale (1,637 shares)
2026-08-17Open-market sale (1,871 shares)
2026-08-17Open-market sale (2,279 shares)

Keywords

insider transaction, Form 4, TNYA, Tenaya Therapeutics, Inc., bearish, Whittemore Tingley

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.